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Background. Social support has been shown to mitigate social barriers to medication adherence and improve tuberculosis (TB)
treatment success rates. The use of mobile technology to activate social support systems among TB patients, however, has not
been well explored. Moreover, studies that tie supportive SMS (Short Message Service) texts to electronic monitoring of TB
medication adherence are lacking. Objective. To explore TB patients’ current access to social support and perceptions of utilizing
real-time adherence monitoring interventions to support medication adherence. Methods. We purposively selected TB patients
who owned phones, had been taking TB medications for ≥1 month, were receiving their treatment from Mbarara Regional
Referral Hospital, and reported having ≥1 social supporter. We interviewed these patients and their social supporters about their
access to and perceptions of social support. We used STATA 13 to describe participants’ sociodemographic and social support
characteristics. Qualitative data were analyzed using content analysis to derive categories describing accessibility and
perceptions. Results. TB patients report requesting and receiving a variety of diﬀerent forms of social support, including
instrumental (e.g., money for transport and other needs and medication reminders), emotional (e.g., adherence counselling),
and informational (e.g., medication side eﬀects) support through mobile phones. Participants felt that SMS notiﬁcations may
motivate medication adherence by creating a personal sense of obligation to take medications regularly. Participants anticipated
that limited ﬁnancial resources and relationship dynamics could constrain the provision of social support especially when
patients and social supporters are not oriented about their expectations. Conclusion. Mobile telephones could provide alternative
approaches to providing social support for TB medication adherence especially where patients do not stay close to their social
supporters. Further eﬀorts should focus on optimized designs of mobile phone-based applications for providing social support
to TB patients and training of TB patients and social supporters to match their expectations.
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1. Introduction
Globally, Uganda ranks among the 30 countries with the
highest burden of TB (tuberculosis), with a prevalence rate
of 253/100,000 people and an incidence rate of 201/100,000
people [1]. Although treatment is freely available in Uganda,
signiﬁcant treatment adherence challenges remain, constrain-
ing TB treatment success and increasing its transmission.
The implementation of DOTS (Direct Observed Treatment
Short Course) has been limited in Uganda. This is because
DOTS demands signiﬁcant time and ﬁnancial burden from
patients as they travel to the clinic; it also demands time com-
mitment from health workers and treatment supporters who
have to supervise patients taking their medication [2]. Social
factors such as poverty, stigma, and limited knowledge of
tuberculosis (TB) can constrain adherence to tuberculosis
medications [3–8]. Provision of social support, deﬁned as
instrumental, emotional, and informational assistance from
one’s social network, can enhance TB medication adherence
by mitigating the social barriers to medication adherence. For
instance, money can facilitate transport to the clinic for pill
reﬁlls, while encouragement or positive feedback makes peo-
ple feel cared for and empowered to cope with stigma and
social discrimination [9, 10]. Importantly, social support
has been shown to improve clinical outcomes, such as the
treatment success rate [11].
Traditional approaches to providing social support (such
as face-to-face counselling interventions) may be limited by
geographical boundaries and are often expensive due to the
time and transport costs involved. Given the widespread
adoption of wireless technologies, such as mobile phones in
sub-Saharan Africa (76% ownership in 2015; [12]), these
technologies can provide accessible and potentially aﬀord-
able means of providing social support. In a recent study car-
ried out in central Uganda, 75% of TB patients reported
owning mobile phones and being willing to receive TB-
related communication via their phones [13]. Mobile phones
are thus a promising alternative approach for providing
social support to TB patients.
Prior studies have utilized mobile technology to support
adherence to TB medications, including randomized, con-
trolled trials of SMS reminders in Pakistan [14], daily
mobile phone calls in Thailand [15], and video directly
observed therapy (VDOT) in California and Mexico [16].
These approaches have generally been found feasible and
acceptable [16] and have also shown improvements in clin-
ical outcomes, including treatment completion and sputum
conversion rates in some studies (e.g., [15]) but not all (e.g.,
[17]). Overall, mobile technology is becoming widely used
to support TB adherence, although the majority of studies
have focused on reminders and DOT (directly observed
therapy). Moreover, the use of mobile technologies to acti-
vate social support systems has not been well explored.
Moreover, there is lack of studies that tie supportive SMS
texts to electronic monitoring (which may be an attractive
alternative to DOT) although limited evidence in HIV is
promising [18–20].
In this study, we used a parallel mixed-method design to
explore the types of social support that adults with presumed
drug-sensitive TB in rural Uganda receive during TB treat-
ment and to assess how patients utilize mobile phones to
obtain social support. We also explored how these adults
would perceive social support for a possible future TB adher-
ence intervention that we were planning. This intervention
includes (1) real-time audits of adherence using a digital
monitoring device, (2) SMS reminders to patients, and (3)
SMS notiﬁcations to patients’ social supporters. WHO [21]
guidelines recommend directly observed therapy (DOT)
using a community-based model in which a family member
or close friend is designated as an adherence supporter,
which includes the responsibility to watch the patient take
his or her medications every day. In this study, we deﬁne
social supporters as friends or family who have previously
helped TB patients with medication or other needs (such as
transport to clinic, food, child care, and/or guidance).
2. Materials and Methods
2.1. Study Design and Setting. This formative study employed
a parallel mixed-method study design that utilized semistruc-
tured interviews and surveys. TB patients were recruited
from the TB clinic within Mbarara Regional Referral Hospi-
tal (MRRH) in rural, southwestern Uganda. Uganda ranks
among the 30 countries with the highest burden of TB/HIV
in the world in 2017 [22]. The treatment completion rate
stands at 75% in Uganda [23]. The Mbarara TB unit provides
care to approximately 600 TB patients annually. TB treat-
ment to newly diagnosed patients is provided according to
WHO guidelines [21] with a daily short course regimen
delivered in ﬁxed-dose combination tablets containing isoni-
azid, rifampin, pyrazinamide, and ethambutol for two
months. At the two-month visit, sputum is examined, and
those who convert the smear examinations to negative con-
tinue with isoniazid and rifampin only for four months in
the continuation phase. The period of treatment can be
extended up to eight months to cater for missed medication
pick-ups. All patients with new cases of TB self-administer
their medications. The clinic does not employ directly
observed therapy due to inadequate staﬀ time and excessive
travel costs for patients to attend the clinic.
2.2. Selection of Study Participants. Between June 2017 and
June 2018, authors AMT and WT purposively selected
patients receiving TB treatment in Mbarara. We aimed to
achieve balanced representation by gender and HIV status
to elicit diverse perspectives. Inclusion criteria for TB patient
participants were as follows: (a) having documented drug-
sensitive TB, (b) receiving treatment with a ﬁrst-line 6-
month course of anti-TB regimen as described above for at
least one month, (c) having a personal mobile phone, (d) able
to send and receive SMS, (e) being 18 years or older, (f) resid-
ing in Mbarara district, (g) being willing and able to give con-
sent, (h) being willing and able to name one social supporter,
and (i) being able to speak the local language (Runyankole)
or English.
We asked patients to identify social supporters at enroll-
ment on the basis of an ongoing relationship, social sup-
porter knowledge of the patient’s TB status, and previous or
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current provision of social support (e.g., assistance to travel
to the clinic and/or medication adherence advice) to the
study participant. Inclusion criteria for the social supporter
participants were as follows: (a) owning a personal mobile
phone, (b) being able to send and received SMS, (c) being
18 years or older, (d) residing in Mbarara district, (e) know-
ing the study participant’s TB/HIV status (ascertained
through patients’ self-reports), and (f) willing and able to
provide consent.
2.3. Study Procedures
2.3.1. Intervention Demonstration. At enrollment, and before
conducting each interview, we oriented each participant
about the planned interventions to support adherence to
TBmedication. First, we explained that a real-time adherence
monitor (Wisepill device; Wisepill Technologies, Cape
Town, South Africa; Figure 1) is a pill bottle that records a
date-and-time stamp when opened. We demonstrated how
the adherence monitor works, including how to open it and
put tablets in and how to close it after taking tablets. We
indicated that the device monitors openings as proxies of
medication ingestion and sends alerts to researchers if it is
not opened by the expected time. We demonstrated how
the monitor holds up to 28 tablets of TB medication. Partic-
ipants were then given the monitor and asked to explain
what it does and to practically demonstrate how it works
to the researcher. We then explained to participants how
we will send SMS reminders on a scheduled (e.g., daily) or
triggered (e.g., triggered by a delayed/missed dose as detected
through the monitor) basis to TB patients to help them take
their medications. We further explained that the device could
send SMS notiﬁcations of nonadherence to the patients’
social supporters to encourage provision of assistance to
the patient.
2.3.2. Data Collection. Immediately after orienting partici-
pants about the intervention (at enrolment), authors WT
and AMT administered surveys eliciting information about
sociodemographics, health status, social support, and general
preferences for the planned wireless intervention. Within
two weeks of enrolment, WT, AM, and AMT carried out
semistructured in-depth interviews with TB patients (fol-
lowing reorientation about the intervention); both authors
are bilingual in English and Runyankole and trained in
qualitative research and research ethics. All questions in
the interview guide were translated into Runyankole and
back-translated to English by a diﬀerent translator. Inter-
views were conducted in Runyankole, digitally recorded,
transcribed, and translated to English. Interviews were con-
ducted in a private space at the research oﬃce near the
MRRH. Each interview lasted between 30 and 60 minutes.
We elicited information about any current social support
obtained by TB patients and how they feel about the social
support they obtain, as well as their expectations of the wire-
less adherence monitoring intervention vis-à-vis social sup-
port. In interviews with social supporters, we also solicited
information about the challenges they faced in providing
medication adherence-related social support to TB patients
and how the intervention might inﬂuence these challenges.
Interviews were conducted until thematic saturation was
achieved. Following each interview, author AM, with support
from JEH and JLD, reviewed the transcripts for quality, clar-
ity, and detail.
2.3.3. Analysis. Participants’ sociodemographic details and
preferences were summarized descriptively using STATA
13 by ATM and TW. We used inductive content analysis
[24] to derive qualitative categories describing how partic-
ipants currently use their phones to support TB-related
treatment and how they perceived the planned wireless
adherence monitoring intervention. Initially, AM, WT, and
ATM reviewed and discussed 20% of transcripts for content
relevant to current social support and expectations of the
intervention. AM and WT then assembled a codebook from
the identiﬁed concepts, using an iterative process, which
included developing codes to represent content, writing
operational deﬁnitions, and selecting illustrative quotes.
JEH, JLD, and DB also reviewed and discussed the codebook.
Diﬀerences in coding were harmonized through discussion.
Following completion of the codebook, interviews were
coded by AM and WT using NVIVO 11.
2.3.4. Ethical Approval. Ethical approvals were obtained from
the Research Ethics Committee of Mbarara University of Sci-
ence and Technology, the Uganda National Council for Sci-
ence and Technology, and the Partners Human Research
Committee for Massachusetts General Hospital.
3. Results and Discussion
3.1. Participant Characteristics. Of 53 screened TB patients,
18 (34%) were excluded for the following reasons (individ-
uals could have >1 criterion): having no cellphone (n = 6;
11.3%), inability to use SMS text messages (n = 5; 9.4%),
unwillingness or inability to name at least one social sup-
porter (n = 3; 5.7%), being <18 years old (n = 2; 3.8%), having
drug-resistant TB (n = 1; 1.9%), and/or inability to provide
informed consent (n = 1; 1.9%). A total of 35 TB patients,
of whom 15 (42.8%) were persons living with HIV/AIDS,
enrolled in the study between February 2017 and April 2018.
Of 24 screened social supporters, 15 (62.5%) were
enrolled in the study. Nine social supporters were excluded
for the following reasons (individuals could have >1 crite-
rion): having no cellphone (n = 3; 12.5%), living beyond
Figure 1: The Wisepill device.
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Mbarara district (n = 2; 8.33%), not knowing the study par-
ticipant’s TB/HIV status (n = 2; 8.3%), being <18 years of
age (n = 1; 4.2%), and inability to provide informed consent
(n = 1; 4.2%).
The sociodemographics, self-reported HIV status, and
TB treatment progress of the study participants are indicated
in Table 1. Just over half of the TB patients were male and the
median age was 32 years. The mean period of TB treatment
completed at the time of interview was 3.3 months. Most
social supporters were female with a median age of 37 years.
The majority of social supporters were TB patients’ biological
relatives (n = 8, 53%), 4 (27%) were spouses, and 3 (20%)
were friends.
3.2. Survey Results. The most frequently reported type of
social support was being reminded/encouraged to take med-
ication—24 (69%) (Table 2). The majority of patients also
reported that they were currently not receiving enough
social support—21 (60%). Patients preferred SMS notiﬁca-
tions that do not instruct how social supporters should
help—20 (57.2%), compared to notiﬁcations that do oﬀer
such guidance.
3.3. Interview Results. TB patient participants reported utiliz-
ing mobile phones to obtain social support related to TB
medication and treatment by (1) requesting and receiving
instrumental support from social supporters, (2) requesting
and receiving emotional support from social supporters,
and (3) receiving informational support from healthcare
providers. In reference to the anticipated intervention, social
supporters and TB patients reported that SMS notiﬁca-
tions may motivate medication adherence. Social supporters
reported being concerned that they would at times be unable
to provide the required support. TB patients reported the
possibility of strain on relationships as a result of sending
notiﬁcations linked to missed doses to social supporters. TB
patients highlighted the need for the clinic/researchers to ori-
ent social supporters and patients about their expectations
after receiving SMS notiﬁcations of nonadherence.
3.4. Use of Mobile Phones for Social Support
3.4.1. Requesting and Receiving Instrumental Support. TB
patients described having used mobile phones to call their
social supporters to request and obtain ﬁnancial assistance
in the form of mobile money (i.e., money sent and received
using mobile phones). Patients reported using the obtained
ﬁnancial assistance to transport themselves to the clinic to
obtain TB medication, buy food and drinks to ease pill tak-
ing, and pay bills both related and unrelated to TB (e.g., clinic
bills, children’s school fees, and housing bills).
Interviewer (I): What challenges do you face in
picking your TB medication from the hospital?
For example, how do you normally come to the
hospital to pick your TB medication?
Respondent (R): When I got sick, I moved to
stayed with my sister so that she can assist me
with washing, cooking, and generally taking care
of me when I am too weak. So, I do not stay with
my mother who provides money for transport to
the clinic for my medication. I always have to use
my mobile phone to call my mother to send me
transport using mobile money. (Female, 39 yrs,
TB patient living with HIV)
This support was particularly helpful for patients without
a regular source of income.
3.4.2. Requesting and Receiving Emotional Support. TB
patients reported using mobile phones to call their social sup-
porters, who in turn provided them with multiple forms of
emotional social support. Common modes of emotional sup-
port included encouraging patients to take medication,
encouraging them to live positively, and accompanying them
to the TB clinic.








Female 15 (42.9%) 9 (60.0%)
Median age in years 32.0 37.0
Able to read English 27 (77.1%) 10 (66.7%)
Able to read Runyankole 34 (97.1%) 14 (93.3%)
Had regular income 18 (51.4%) 8 (53.3%)
Worried about food security 20 (57.1%) 8 (53.3%)
Living with HIV 15 (42.9%) 1 (6.7%)
Mean (standard deviation) of TB
treatment period completed (months)
3.3 (1.5) —
Table 2: Survey results from patients.
Current social support received by patients∗
Reminders/encouragement to take medication 24 (69%)
Transport to clinic 21 (60%)
Food and drinks 20 (57%)
Help with chores 20 (57%)
Assistance with child care 10 (29%)
Counselling (e.g., encouragement to
be positive about having TB)
5 (14%)
Money for other needs 3 (9%)
Adequacy of the social support received
Social support enough 14 (40%)
Social support not enough 21 (60%)
Preference of notiﬁcations of social supporter
Preferred notiﬁcations that instruct
how the social supporter should help
15 (43%)
Preferred notiﬁcations that do not
instruct how the social supporter should help
20 (57%)
∗Participants could select multiple responses.
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I: Please tell me about a time when someone used
a mobile phone to help you with anything related
to your TB?
R: I used my phone to call my sister, and she
escorted me to the hospital, and took me to the
theatre. She would encourage me to take medi-
cine, and ensured that I was taken good care of
myself.
I: How did you feel about the support that she
gave to you?
R: I felt good and cared for because she is the one
that was always with me.
I: So why do you think she helped you the way she
helped you?
R: She helped because she cares about my life.
(Female, 28 yrs, TB patient)
Patients described feeling good and cared for when their
social supporters checked on them during telephone and
SMS interactions.
3.4.3. Informational Support from Healthcare Providers. In
addition to their social networks, TB patients also reported
using their mobile phones to call healthcare providers and
inquire about side eﬀects, such as feeling dizzy or experienc-
ing a change of urine color after taking the medication. These
calls helped patients get useful medication-related advice,
such as the need to eat and drink before taking medication.
I: First, I would like to know a little about how
you use your cell phone. Do you ever use your
phone for anything related to your health?
R: Yes. Sometimes when I take mymedication and
become dizzy I call the nurse nearby our trading
center called X and she tells me what to do.
I: Please tell me more about that.
R: When I call her, she tells me that it’s the side
eﬀect of the TB pills and that to reduce it, I need
to drink a lot and ensure that I do not take med-
icine on an empty stomach. (Female, 37 yrs, TB
patient)
TB patients, especially those who stayed far from the
clinic, reported calling healthcare providers to make inqui-
ries about the availability of drugs and clinic opening times.
This information saved patients the expense of having to buy
medicine from private pharmacies when they are freely
available at the public clinic or traveling to the clinic outside
operating hours.
I: Have you ever gotten assistance in taking your
TB medication through your mobile phone?
R: Yes I have ever called a doctor because I
wanted to ﬁnd out about the availability of the
drugs at the TB treatment unit. The doctor told
me that the drugs are always available and
advised me to always come and pick the medica-
tion. He also discouraged me from buying medi-
cation from the pharmacy in case of failure to
come to the hospital because they are expensive
in terms of costs. (Male 39 yrs, TB patient)
Instrumental and emotional support from friends and
family, as well as informational support from clinicians,
are important resources that can be accessed using mobile
phones and used to facilitate completion of TB treatment.
3.5. Perceptions about the Planned Intervention
3.5.1. SMS Notiﬁcations to Social Supporters May Motivate
TB Medication Adherence. Regarding the planned wireless
adherence monitoring technology, social supporters and TB
patients reported that receiving SMS texts when patients miss
taking medication may “force” TB patients “not to forget tak-
ing medicine on time.” This “force” was described positively,
because it is motivated by the shared desire for the patient to
get well.
I: How do you think [study participant] will feel
when he knows that you receive his SMS when
he misses taking his medication?
R: He will like it very well and knowing that I will
receive his SMS text when he misses taking his
medication will force him not to forget taking
his medicine on time.
I: Why would he be forced not to forget?
R: He knows me as a very strict person who has
cared about his sickness since testing up to now.
I agreed with him to always tell me, how he picks
his medication and whenever he does medical
checkup since it’s me who gives him transport as
my son. (Male, 65 years, social supporter)
I: How do you feel about sending SMS notiﬁca-
tion to your social supporter when you miss tak-
ing your pills in time?
R: It is a good thing because it will help me get
cured quickly.
I: Please tell me more about that.
R: It forces me to take my drugs on time to get
well, and also make him happy by seeing that
he did not waste his eﬀorts in supporting me.
(Male, 45 years, patient)
Social supporters felt that access to updates about
patients’ adherence would create a personal sense of obliga-
tion to take medication on time among patients.
3.5.2. Economic Constraints Could Limit Resources to
Provide Support. Despite the anticipated motivation, partici-
pants had some concerns about implementing the planned
intervention. First, although social supporters reported a
desire and willingness to assist TB patients, those without a
regular source of income reported being worried about the
possibility of not being able to provide support for the TB
patients even after receiving the SMS notiﬁcation from the
planned intervention.
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It is not easy for me now, and it would not be easy
for me when you send me a notiﬁcation. I have to
provide him all the support he needs to take his
medicine well. Yet, I am also a poor woman
struggling to live. (Female, 63, social supporter)
This inability to provide support when needed created
feelings of disappointment and embarrassment for both the
social supporters and TB patients.
3.5.3. Receipt of the Planned SMS Notiﬁcations Could Strain
Relations. Second, in addition to stress arising from limited
resources, some TB patients and social supporters expressed
concern that adherence-related messages could introduce
conﬂict into their relationships. For example, patients noted
that receiving notiﬁcations of missed doses could strain their
relationship with social supporters.
“Once she knows that I have missed taking my
medication and she has received an SMS notiﬁca-
tion from you. I am sure she will quarrel with me.
Most of the times when she ﬁnds that I have for-
gotten taking my TB medication, she quarrels.”
(Male, 50 yrs, TB patient)
This strain could potentially negatively aﬀect the rela-
tionships between TB patients and their social supporters.
3.5.4. Orienting Social Supporters and TB Patients May
Improve the Impact of SMS Notiﬁcations. In response to these
challenges, TB patients and social supporters described the
need to be oriented about the planned SMS notiﬁcations.
This orientation could be done by the clinic or researchers
and should highlight times and/or scenarios when SMS noti-
ﬁcations can be sent and multiple ways how social supporters
can help. During these orientations, patients can be helped to
understand that social supporters may at times be unable to
provide instrumental support due to inadequate resources.
I: So do you want the SMS notiﬁcations to inform
your social supporter that you forgot to swallow
your TB medication in order for her to help you
well in taking you are TB medication?
R: The best thing is to tell me to come with her
here and you teach both of us so that each of us
knows what to do after receiving the SMS. (Male,
50 yrs, TB patient)
Providing orientation may be helpful in matching expec-
tations of TB patients and their social supporters.
4. Discussion
In this mixed-method study of social support for adherence
to TB treatment, TB patients described requesting and
receiving instrumental, emotional, and informational social
support using their mobile phones. Reminders and encour-
agement were the most common type of support received,
followed by transport to the clinic, food and drinks, and help
with chores. Participants felt that SMS notiﬁcations may
motivate medication adherence by creating a personal sense
of obligation to take medication on time. However, TB
patients and social supporters reported that limited resources
and relationship dynamics may constrain the provision of
social support. Participants expressed the need to be oriented
about the use of SMS notiﬁcations before they start receiving
them in order to match expectations of patients and those of
social supporters.
Traditional approaches to providing social support (such
as counselling support, family and community support, and
health education) have been shown to positively impact TB
treatment success [9, 10]. A systematic review by van Hoorn
and colleagues (which includes studies from low income
countries of Nepal, Burkina Faso, and Haiti) reports that
social support in the form of counseling, food supplements,
home visits, and economic support improves TB treatment
completion [25]. Other studies [26, 27] report the positive
inﬂuence of instrumental support (in the form of monetary
incentives and food packages) on TB treatment success and
TB medication adherence in Asia and Russia. A randomized,
controlled trial carried out by Tola and colleagues reports
decreased nonadherence to TB medication adherence as a
result of a social support intervention composed of counsel-
ling and health education in Ethiopia [28]. Despite the bene-
ﬁts, traditional approaches for providing social support may
involve transport and time burdens, especially among
patients who do not stay close to their social supporters.
Delivering social support using mobile phones may be an
inexpensive, accessible, and convenient approach that can
potentially overcome geographical barriers to the provision
of social support.
In this study, TB patients and their supporters largely
agreed that SMS reminders linked to adherence monitoring
technology could improve adherence. Such interventions
have been shown to increase adherence to HIV antiretroviral
therapy. In China, mobile phone-based SMS reminders
are reported to be acceptable and useful in establishing
antiretroviral adherence routines [29]. In South Africa,
adherence measured by a real-time monitoring technology
emerged as one of the best predictors of antiretroviral
drug resistance and virological failure [30]. In the same
setting in Uganda, a mobile adherence monitoring interven-
tion composed of real-time adherence technology and SMS
reminders was reported to be acceptable [19] and to
improve adherence to antiretroviral therapy [18]. Similar
or related interventions need to be tested in supporting
TB medication adherence.
Our ﬁndings emphasize the need for researchers and
intervention designers to consider social support in light of
complex interpersonal relationships. Sending SMS notiﬁca-
tions to social supporters when patients miss their TB medi-
cations may motivate patients to consistently take their
medication on time to avoid letting down the eﬀorts of
social supporters who are caring for their health. Social
supporters’ frequent receipt of SMS notiﬁcations may, how-
ever, be perceived as patients’ lack of commitment to med-
ication adherence. This scenario may potentially result in
misunderstandings which may aﬀect the quality of support
6 Tuberculosis Research and Treatment
provided and the relationship itself, as noted by our partic-
ipants. Additionally, the anticipated conﬂict as a result of
unmatched or unmet expectations between patients and
their social supporters was indeed reported in the antiretro-
viral adherence intervention in the same setting [31] and
no deﬁnitive beneﬁt of social support was seen [18].
Since ﬁndings indicate that potential strain on relation-
ships and resources could limit the feasibility/acceptability
of social support interventions, managing such strains is
likely critical to the successful implementation of these inter-
ventions. Mobile phone-based support has a great potential,
but the complexities of resource scarcity and interpersonal
relationships necessitate careful human management of the
process. Additional interventions for boosting the economic
status (e.g., [32]) of social supporters or identifying alterna-
tive sources of support when possible (e.g., other members
of the patient’s social network) may improve the feasibility
of the social support intervention. Providing orientation
and counseling to patients and social supporters could also
help in clarifying their roles, managing and harmonizing
expectations, and highlighting the negative eﬀect of persis-
tent nonadherence on relationships.
This study has some limitations. Since we used purpo-
sive sampling, the proportions may not accurately summa-
rize the characteristics or opinions of the overall TB
patient and supporter populations from which we selected.
It is based on a single setting—results may be diﬀerent in dif-
ferent settings where culture, use of technology, resources,
interpersonal dynamics, and other factors vary. The study
only included patients who possess mobile phones and know
how to use SMS texts; patients without phones or/and with-
out knowledge of using SMS texts may have diﬀerent views.
This study is also based on self-reported responses about
sensitive topics, which may be vulnerable to social desirabil-
ity bias. Importantly, several of our ﬁndings reﬂect views of
an anticipated intervention without the beneﬁt of experi-
ence of the intervention. Experiences with the intervention
will be assessed in an upcoming trial (NCT03800888). This
study also has a number of strengths. First, the achievement
of theme saturation suggests the sample was adequate. The
study highlights potential ways in which mobile phones
could be used to promote TB medication. Our ﬁndings
are important for understanding the potential acceptability
of the use of SMS texts combined with electronic monitoring
to support TB medication adherence, which may potentially
be an attractive alternative to DOT. Additionally, these ﬁnd-
ings can inform ideal study design for future mobile health-
based and other related interventions.
5. Conclusions
Mobile telephones could provide alternative approaches to
providing social support for TB medication adherence espe-
cially where patients do not stay close to their social sup-
porters. This could relieve transport and time burdens
associated with traditional face-to-face delivery of support.
This advantage may be particularly useful in resource-
limited settings where mobile phones are widely adopted
and other support is diﬃcult to obtain. Further eﬀorts
should focus on optimized designs of mobile phone-based
applications for providing social support to TB patients
and training of TB patients and social supporters to match
their expectations.
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